These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 34157885)
61. Evaluation of Patient-Reported Satisfaction and Clinical Efficacy of Once-Weekly Semaglutide in Patients with Type 2 Diabetes: An Ambispective Study. Al Hayek AA; Al Dawish MA Adv Ther; 2022 Apr; 39(4):1582-1595. PubMed ID: 35119622 [TBL] [Abstract][Full Text] [Related]
62. An Indirect Treatment Comparison of Semaglutide 2.0 mg vs Dulaglutide 3.0 mg and 4.5 mg Using Multilevel Network Meta-regression. Lingvay I; Bauer R; Baker-Knight J; Lawson J; Pratley R J Clin Endocrinol Metab; 2022 Apr; 107(5):1461-1469. PubMed ID: 34922383 [TBL] [Abstract][Full Text] [Related]
63. Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial. Yabe D; Nakamura J; Kaneto H; Deenadayalan S; Navarria A; Gislum M; Inagaki N; Lancet Diabetes Endocrinol; 2020 May; 8(5):392-406. PubMed ID: 32333876 [TBL] [Abstract][Full Text] [Related]
64. Clinical review of the efficacy and safety of oral semaglutide in patients with type 2 diabetes compared with other oral antihyperglycemic agents and placebo. Lavernia F; Blonde L Postgrad Med; 2020 Nov; 132(sup2):15-25. PubMed ID: 32815436 [TBL] [Abstract][Full Text] [Related]
65. Semaglutide for type 2 diabetes mellitus: A systematic review and meta-analysis. Andreadis P; Karagiannis T; Malandris K; Avgerinos I; Liakos A; Manolopoulos A; Bekiari E; Matthews DR; Tsapas A Diabetes Obes Metab; 2018 Sep; 20(9):2255-2263. PubMed ID: 29756388 [TBL] [Abstract][Full Text] [Related]
66. Semaglutide: Review and Place in Therapy for Adults With Type 2 Diabetes. Goldenberg RM; Steen O Can J Diabetes; 2019 Mar; 43(2):136-145. PubMed ID: 30195966 [TBL] [Abstract][Full Text] [Related]
67. Efficacy of oral semaglutide: overview of the PIONEER clinical trial program and implications for managed care. Rodbard HW; Dougherty T; Taddei-Allen P Am J Manag Care; 2020 Dec; 26(16 Suppl):S335-S343. PubMed ID: 33439582 [TBL] [Abstract][Full Text] [Related]
68. Semaglutide is effective in achieving weight loss in liver transplant recipients. Chow KW; Ibrahim B; Rahal K; Hsu RH; Tan T; Meneses K; Saab S Liver Transpl; 2024 Feb; 30(2):223-225. PubMed ID: 37639288 [No Abstract] [Full Text] [Related]
69. Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: An adjusted indirect treatment comparison. Vadher K; Patel H; Mody R; Levine JA; Hoog M; Cheng AY; Pantalone KM; Sapin H Diabetes Obes Metab; 2022 Sep; 24(9):1861-1868. PubMed ID: 35589616 [TBL] [Abstract][Full Text] [Related]
70. Semaglutide for the treatment of type 2 Diabetes Mellitus: A systematic review and network meta-analysis of safety and efficacy outcomes. Zaazouee MS; Hamdallah A; Helmy SK; Hasabo EA; Sayed AK; Gbreel MI; Elmegeed AA; Aladwan H; Elshanbary AA; Abdel-Aziz W; Elshahawy IM; Rabie S; Elkady S; Ali AS; Ragab KM; Nourelden AZ Diabetes Metab Syndr; 2022 Jun; 16(6):102511. PubMed ID: 35623229 [TBL] [Abstract][Full Text] [Related]
71. Semaglutide Once Weekly Helps Adolescents Lose Weight, but 4% Developed Acute Cholelithiasis. Ebell MH Am Fam Physician; 2023 Jul; 108(1):Online. PubMed ID: 37440751 [No Abstract] [Full Text] [Related]
72. Efficacy and safety of oral semaglutide by subgroups of patient characteristics in the PIONEER phase 3 programme. Aroda VR; Bauer R; Christiansen E; Haluzík M; Kallenbach K; Montanya E; Rosenstock J; Meier JJ Diabetes Obes Metab; 2022 Jul; 24(7):1338-1350. PubMed ID: 35373893 [TBL] [Abstract][Full Text] [Related]
73. Once-Weekly Semaglutide Is an Effective Adjunct for Weight Loss in Adults without Diabetes Who Are Overweight or Obese. Slawson DC Am Fam Physician; 2021 Jul; 104(1):96-97. PubMed ID: 34264618 [No Abstract] [Full Text] [Related]
74. Effect of once-weekly semaglutide versus thrice-daily insulin aspart, both as add-on to metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUSTAIN 11): A randomized, open-label, multinational, phase 3b trial. Kellerer M; Kaltoft MS; Lawson J; Nielsen LL; Strojek K; Tabak Ö; Jacob S Diabetes Obes Metab; 2022 Sep; 24(9):1788-1799. PubMed ID: 35546450 [TBL] [Abstract][Full Text] [Related]
75. Indirect treatment comparisons: Choosing the right tool for the job. Pratley RE; Gorst-Rasmussen A Diabetes Obes Metab; 2022 Jun; 24(6):1180-1181. PubMed ID: 35129275 [No Abstract] [Full Text] [Related]
76. Real-world use of once-weekly semaglutide in patients with type 2 diabetes at an outpatient clinic in Spain. Garcia de Lucas MD; Miramontes-González JP; Avilés-Bueno B; Jiménez-Millán AI; Rivas-Ruiz F; Pérez-Belmonte LM Front Endocrinol (Lausanne); 2022; 13():995646. PubMed ID: 36187123 [TBL] [Abstract][Full Text] [Related]
77. Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Results from the SURE Switzerland multicentre, prospective, observational study. Rudofsky G; Catarig AM; Favre L; Grau K; Häfliger S; Thomann R; Schultes B Diabetes Res Clin Pract; 2021 Aug; 178():108931. PubMed ID: 34217773 [TBL] [Abstract][Full Text] [Related]
78. Clinical review of the efficacy and safety of oral semaglutide in patients with type 2 diabetes considered for injectable GLP-1 receptor agonist therapy or currently on insulin therapy. Wright EE; Aroda VR Postgrad Med; 2020 Nov; 132(sup2):26-36. PubMed ID: 32815423 [TBL] [Abstract][Full Text] [Related]
79. Editorial commentary: Weight loss for cardiovascular disease prevention - is semaglutide the answer? Lavie CJ; Bhatt DL; Neeland IJ; Heymsfield SB Trends Cardiovasc Med; 2023 Apr; 33(3):167-169. PubMed ID: 34999021 [No Abstract] [Full Text] [Related]
80. Real-World Effectiveness of Once-Weekly Semaglutide From a US Commercially Insured and Medicare Advantage Population. Visaria J; Uzoigwe C; Swift C; Dang-Tan T; Paprocki Y; Willey VJ Clin Ther; 2021 May; 43(5):808-821. PubMed ID: 33785221 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]